Get started
Author

Srijita Chowdhury

Observed name: Chowdhury, Srijita
ORCID: 0000-0001-7785-984X
Observed ORCID: 0000-0001-7785-984X
OpenAlex ID: A5040367171
An Updated Review on Influenza Viruses
2023 · Unnati Bhalerao, Anil Kumar Mavi, et al. · Springer eBooks · 7
Exploring the potential of amyloids in biomedical applications: A review
2023 · Srijita Chowdhury, Nandini Sarkar · Biotechnology and Bioengineering · 6
PDF
Novel Diagnostic Methods for Emerging Respiratory Viral Infection
2023 · Sakshi, Anil Kumar Mavi, et al. · Springer eBooks · 6
Combine mitochondrial-targeted gene therapy and chemotherapy to treat triple-negative breast cancer
2025 · Tanvi Varadkar, Zhuoxin Zora Zhou, et al. · Journal of Experimental & Clinical Cancer Research · 4
PDF
Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al. · Cancer Research Communications · 1
Combine antibody-drug conjugate with cmLumiOpto for triple-negative breast cancer treatment
2026 · Tanvi Varadkar, Zhuoxin “Zora” Zhou, et al. · Cell Reports Medicine
Figure 1 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Data from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure 2 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure S4 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure 3 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure S3 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure S1 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure S2 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure 5 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure S7 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure S6 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure 4 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Table 1 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure 7 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure 6 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Figure S5 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026 · Zhuoxin Zhou, Davis Ballard, et al.
Reproducible Computational Analysis for Advanced Dual Payload Antibody-Drug Conjugates
2026 · Zhuoxin “Zora” Zhou, Ballard, Davis, et al. · Code Ocean
Reproducible Computational Analysis for Advanced Dual Payload Antibody-Drug Conjugates
2026 · Zhuoxin “Zora” Zhou, Ballard, Davis, et al. · Code Ocean
Additional file 1 of Combine mitochondrial-targeted gene therapy and chemotherapy to treat triple-negative breast cancer
2025 · Varadkar, Tanvi, Zhou, Zhuoxin Zora, et al. · Figshare
Works count: 28
Citation count: 24
H-index: 4
I10-index:
Year
Topic
Type